Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis.

Nat Genet
Authors
Keywords
Abstract

The genetic architectures of common, complex diseases are largely uncharacterized. We modeled the genetic architecture underlying genome-wide association study (GWAS) data for rheumatoid arthritis and developed a new method using polygenic risk-score analyses to infer the total liability-scale variance explained by associated GWAS SNPs. Using this method, we estimated that, together, thousands of SNPs from rheumatoid arthritis GWAS explain an additional 20% of disease risk (excluding known associated loci). We further tested this method on datasets for three additional diseases and obtained comparable estimates for celiac disease (43% excluding the major histocompatibility complex), myocardial infarction and coronary artery disease (48%) and type 2 diabetes (49%). Our results are consistent with simulated genetic models in which hundreds of associated loci harbor common causal variants and a smaller number of loci harbor multiple rare causal variants. These analyses suggest that GWAS will continue to be highly productive for the discovery of additional susceptibility loci for common diseases.

Year of Publication
2012
Journal
Nat Genet
Volume
44
Issue
5
Pages
483-9
Date Published
2012 Mar 25
ISSN
1546-1718
URL
DOI
10.1038/ng.2232
PubMed ID
22446960
Links
Grant list
R01-AR057108 / AR / NIAMS NIH HHS / United States
R01-AR44422 / AR / NIAMS NIH HHS / United States
MOP79321 / Canadian Institutes of Health Research / Canada
K08AR055688-01A1 / AR / NIAMS NIH HHS / United States
U01 GM092691 / GM / NIGMS NIH HHS / United States
R01-AR059648 / AR / NIAMS NIH HHS / United States
MC_U106179471 / Medical Research Council / United Kingdom
Intramural NIH HHS / United States
090532 / Wellcome Trust / United Kingdom
R01 GM045295 / GM / NIGMS NIH HHS / United States
R01-AR056768 / AR / NIAMS NIH HHS / United States
N01-AR-2-2263 / AR / NIAMS NIH HHS / United States
R01 AR056768 / AR / NIAMS NIH HHS / United States
IIN-84042 / Canadian Institutes of Health Research / Canada
U01-GM092691 / GM / NIGMS NIH HHS / United States